Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: A randomized, double-blind clinical trial

Annals of Emergency Medicine

Volumn 41, Issue 6, 2003, Pages 818-826

  Turturro, Michael A ^a,c   Frater, Craig R ^a   D'Amico, Frank J ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DUQUESNE UNIVERSITY   (United States)

^c MERCY HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOBENZAPRINE; DIAZEPAM; IBUPROFEN; MONOAMINE OXIDASE INHIBITOR; NAPROXEN; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMERGENCY WARD; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOFASCIAL PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VISUAL ANALOG SCALE;

EID: 0037837734     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.188     Document Type: Article

References (18)

1. DeLee JC, Rockwood CA. Skeletal muscle spasm and a review of muscle relaxants. Curr Ther Res. 1980;27:64-74.
2. Cullen AP. Carisoprodol in acute back conditions: a double-blind randomized placebo-controlled study. Curr Ther Res. 1976;20:233-240.
3. Vernon WG. A double blind evaluation of Parafon Forte in the treatment of musculo-skeletal back conditions. Curr Ther Res. 1972;14:801-806.
4. Fathie K. A second look at a skeletal muscle relaxant: a double-blind study of metaxalone. Curr Ther Res. 1964;6:677-683.
5. Cranston JP. Double-blind comparison of Parafon Forte tablets versus Norgesic Forte for the relief of pain and spasm of musculoskeletal disorders. Curr Ther Res. 1977;21:809-814.
6. Gready DM. Parafon Forte versus robaxisol in skeletal muscle disorders: a double blind study. Curr Ther Res Opin. 1976;20:666-672
7. Basmajian JV. Acute back pain and spasm: a controlled multicenter trial of combined analgesic and antispasm agents. Spine. 1989;14:438-439
8. Borenstein DG, Lacks S, Wiesel SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther. 1990;12:125-131.
9. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994;154:157-163.
10. Yaphe J, Edman R, Knishkowy B, et al. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract. 2001;18:565-568.
11. Todd KH, Funk KG, Funk JP, et al. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996;27:485-489.
12. Moreland LW, St Clair EW. The use of analgesics in the management of pain in rheumatic diseases. Rheum Dis Clin. 1999;25:153-191.
13. Nibbelink DW, Strickland SC, McLean LF, et al. Cyclobenzaprine, diazepam, and placebo in the treatment of skeletal muscle spasm of local origin. Clin Ther. 1978;1:409-424.
14. Browning R, Jackson JL, O'Malley PG. Cyclobenzaprine and back pain - a metaanalysis. Arch Intern Med. 2001;161:1613-1620.
15. Deyo RA, Diehl AK, Rosenthal M. How many days of bed rest for acute low back pain? A randomized clinical trial. N Engl J Med. 1986;315:1064-1070.
16. Vroomen PC, Krom MC, Wilmink JT, et al. Lack of effectiveness of bed rest for sciatica. N Engl J Med. 1999;340:418-423.
17. Malmivaara A, Hakkinen U, Aro T, et al. The treatment of acute low back pain - bed rest, exercises, or ordinary activity? N Engl J Med. 1995;332:351-355.
18. Bigos S, Bowyer O, Braen G, et al. Clinical Practice Guideline 14: Acute Lower Back Problems in Adults. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services; 1994. AHCPR Publication No. 95-0642.